|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Change in fair value of warrants | |||||
| Non-cash other financing costs, including change in fair value of derivative | |||||
| Non-cash other financing costs | |||||
| Changes in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Net cash used in operating activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock, net | |||||
| Proceeds from issuance of common stock, warrants, and pre-funded warrants, net | |||||
| Proceeds from exercise of common stock options, net | |||||
| Proceeds from exercise of warrants | |||||
| Net cash provided by financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Reduction in value of warrants related to exercises | |||||
| Cash paid for financing costs | |||||
Loading...